Malignant Thyroid Gland Neoplasm — Trials

Malignant Thyroid Gland Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

790 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 176
Recruiting: 92
Ph III recruiting: 12
Growth YoY: +4.9%
Industry share: 13%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 25.9%
Trials / 1,000 deaths: 81.9 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (65)

clinicaltrialsPublishedShowing 101–108 of 108 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02055989	A Phase I/II Study of the Use of Intensity Modulated Radiotherapy (IMRT) in Cancer of the Thyroid, Larynx and Hypopharynx	completed	Phase 1 / Phase 2	105	Royal Marsden NHS Foundation TrustOTHER	1	Feb 5, 2014	clinicaltrials
NCT01100619	A Drug-Drug Interaction Study of the Effects of XL184 (Cabozantinib) on Rosiglitazone in Subjects With Solid Tumors	completed	Phase 1	40	ExelixisINDUSTRY	1	Sep 19, 2013	clinicaltrials